131
Views
1
CrossRef citations to date
0
Altmetric
Clinical Trial Protocol

Combi-TED: A new Trial Testing Tedopi® with Docetaxel or Nivolumab in Metastatic Non-Small-Cell Lung Cancer Progressing After First Line

, , , , , , , , , , , , , , , , & show all
Pages 4457-4464 | Received 14 Sep 2022, Accepted 30 Nov 2022, Published online: 22 Mar 2023

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.